The international study, led by scientists at the University of Birmingham in collaboration with the University of Würzburg, examined G protein-coupled receptors (GPCRs), specifically the metabotropic glutamate receptor (mGluR4), which mediates the effects of the brain’s main neurotransmitter, in an attempt to establish how the receptors are organised within the brain. While previous research had investigated other types of receptors, very little was known about the organization of metabotropic glutamate receptors and other GPCRs in the brain.
GPCRs play a fundamental role in regulating virtually all physiological processes in the body, enabling cells to sense external stimuli and communicate with each other. Because of this, they are the targets of at least one third of all drugs on the market. When cells are unable to communicate effectively, conditions such as Parkinson’s, diabetes and heart failure can develop. Understanding how these receptors work under normal conditions is key to the development of effective treatments.